The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer

Familial Cancer

Volumn 11, Issue 2, 2012, Pages 243-247

  Laitman, Yael ^a   Herskovitz, Liron ^a   Golan, Talia ^b   Kaufman, Bella ^b   Paluch, Shani Shimon ^b   Friedman, Eitan ^a,c  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Gastric cancer; HNPCC; Inherited predisposition; MSH2 MSH6 genes; Pancreatic cancer

Indexed keywords

ADULT; ARTICLE; CAPILLARY ELECTROPHORESIS; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE; GENE MUTATION; GENOTYPE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HISTOPATHOLOGY; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MSH2 GENE; MSH6 GENE; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CANCER;

AGED; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA-BINDING PROTEINS; FEMALE; FOUNDER EFFECT; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; ISRAEL; JEWS; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; PANCREATIC NEOPLASMS; PEDIGREE; STOMACH NEOPLASMS;

EID: 84864677303     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-011-9507-1     Document Type: Article

References (23)

1. Schrader K, Huntsman D (2010) Hereditary diffuse gastric cancer. Cancer Treat Res 155:33-63
2. Hruban RH, Klein AP, Eshleman JR, Axilbund JE, Goggins M (2007) Familial pancreatic cancer: From genes to improved patient care. Expert Rev Gastroenterol Hepatol 1(1):81-88
3. Slater EP, Langer P, Niemczyk E, Strauch K, Butler J, Habbe N, Neoptolemos JP, Greenhalf W, Bartsch DK (2010) PALB2 mutations in European familial pancreatic cancer families. Clin Genet 78(5):490-494
4. Stadler ZK, Salo-Mullen E, Patil SM, Pietanza MC, Vijai J, Saloustros E, Hansen NA, Kauff ND, Kurtz RC, Kelsen DP, Offit K, Robson ME (2011) Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. Cancer. doi:10.1002/cncr.26191 [Epub ahead of print]
5. The Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310-1316
6. Jasperson KW, Tuohy TM, Neklason DW, Burt RW (2010) Hereditary and familial colon cancer. Gastroenterology 138(6):2044-2058
7. Sheng JQ, Chan TL, Chan YW, Huang JS, Chen JG, Zhang MZ, Guo XL, Mu H, Chan AS, Li SR, Yuen ST, Leung SY (2006) Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer. Chin J Dig Dis 7(4):197-205
8. Lucci-Cordisco E, Rovella V, Carrara S, Percesepe A, Pedroni M, Bellacosa A, Caluseriu O, Forasarig M, Anti M, Neri G, de Leon MP, Viel A, Genuardi M (2001) Mutations of the 'minor' mismatch repair gene MSH6 in typical and atypical hereditary non polyposis colorectal cancer. Fam Cancer 1(2):93-99
9. Banville N, Geraghty R, Fox E, Leahy DT, Green A, Keegan D, Geoghegan J, O'Donoghue D, Hyland J, Sheahan K (2006) Medullary carcinoma of the pancreas in a man with hereditary non polyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene. Hum Pathol 37(11):1498-1502
10. Gargiulo S, Torrini M, Ollila S, Nasti S, Pastorino L, Cusano R, Bonelli L, Battistuzzi L, Mastracci L, Bruno W, Savarino V, Sciallero S, Borgonovo G, Nyström M, Bianchi-Scarrà G, Mareni C, Ghiorzo P (2009) Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. Fam Cancer 8(4):547-553
11. Bonadona V, Bonaïti B, Olschwang S, Grandjouan S, Huiart L, Longy M, Guimbaud R, Buecher B, Bignon YJ, Caron O, Colas C, Noguès C, Lejeune-Dumoulin S, Olivier-Faivre L, Polycarpe-Osaer F, Nguyen TD, Desseigne F, Saurin JC, Berthet P, Leroux D, Duffour J, Manouvrier S, Frébourg T, Sobol H, Lasset C, Bonaïti-Pellié C, French Cancer Genetics Network (2011) Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305(22):2304-2310
12. Talseth-Palmer BA, McPhillips M, Groombridge C, Spigelman A, Scott RJ (2010) MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer. Hered Cancer Clin Pract 8(1):5-14
13. Imai Y, Inoue T, Ishikawa T (1998) Mutations of the human MUT S homologue 6 gene in ampullary carcinoma and gastric cancer. Int J Cancer 78(5):576-580
14. Raskin L, Schwenter F, Freytsis M, Tischkowitz M, Wong N, Chong G, Narod SA, Levine DA, Bogomolniy F, Aronson M, Thibodeau SN, Hunt KS, Rennert G, Gallinger S, Gruber SB, Foulkes WD (2011) Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome. Clin Genet 79(6):512-522
15. Mukherjee B, Rennert G, Ahn J, Dishon S, Lejbkowicz F, Rennert HS, Shiovitz S, Moreno V, Gruber SB (2011) High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation. Gastroenterology 140(7): 1919-1926
16. Guillem JG, Rapaport BS, Kirchhoff T, Kolachana P, Nafa K, Glogowski E, Finch R, Huang H, Foulkes WD, Markowitz A, Ellis NA, Offit K (2003) A636P is associated with early-onset colon cancer in Ashkenazi Jews. J Am Coll Surg 196: 222-225
17. Capelle LG, Van Grieken NC, Lingsma HF, Steyerberg EW, Klokman WJ, Bruno MJ, Vasen HF, Kuipers EJ (2010) Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology 138(2):487-492
18. Goldberg Y, Porat RM, Kedar I, Shochat C, Galinsky D, Hamburger T, Hubert A, Strul H, Kariiv R, Ben-Avi L, Savion M, Pikarsky E, Abeliovich D, Bercovich D, Lerer I, Peretz T (2010) An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC. Fam Cancer 9(2):141-150
19. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24(14):2137-2150
20. Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Garcia EBG, Vriends AH, Barnetson RA, Farrington SM, Tenesa A, Hampel H, Buchanan D, Arnold S, Young J, Walsh MD, Jass J, Macrae F, Antill Y, Winship IM, Giles GG, Goldblatt J, Parry S, Suthers G, Leggett B, Butz M, Aronson M, Poynter JN, Baron JA, Le Marchand L, Haile R, Gallinger S, Hopper JL, Potter J, de la Chapelle A, Vasen HF, Dunlop MG, Thibodeau SN, Jenkins MA (2010) Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst 102(3):193-201
21. Barak F, Milgrom R, Laitman Y, Gemer O, Rabinovich A, Piura B, Anteby E, Baruch GB, Korach J, Friedman E (2010) The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients. Gynecol Oncol 119(3):511-515
22. Patael Y, Figer A, Gershoni-Baruch R, Papa MZ, Risel S, Shtoyerman-Chen R, Karasik A, Theodor L, Friedman E (1999) Common origin of the I1307K APC polymorphism in Ashkenazi and non-Ashkenazi Jews. Eur J Hum Genet 7(5):555-559
23. Bar-Sade RB, Kruglikova A, Modan B, Gak E, Hirsh-Yechezkel G, Theodor L, Novikov I, Gershoni-Baruch R, Risel S, Papa MZ, Ben-Baruch G, Friedman E (1998) The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Hum Mol Genet 7(5):801-805